158 related articles for article (PubMed ID: 37294422)
1. Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas.
Cho NS; Sanvito F; Thakuria S; Wang C; Hagiwara A; Nagaraj R; Oshima S; Lopez Kolkovsky AL; Lu J; Raymond C; Liau LM; Everson RG; Patel KS; Kim W; Yang I; Bergsneider M; Nghiemphu PL; Lai A; Nathanson DA; Cloughesy TF; Ellingson BM
J Neurooncol; 2023 Jun; 163(2):417-427. PubMed ID: 37294422
[TBL] [Abstract][Full Text] [Related]
2. Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T.
Wang YL; Yao J; Chakhoyan A; Raymond C; Salamon N; Liau LM; Nghiemphu PL; Lai A; Pope WB; Nguyen N; Ji M; Cloughesy TF; Ellingson BM
AJNR Am J Neuroradiol; 2019 Jun; 40(6):979-986. PubMed ID: 31097430
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
Karavaeva E; Harris RJ; Leu K; Shabihkhani M; Yong WH; Pope WB; Lai A; Nghiemphu PL; Liau LM; Chen W; Czernin J; Cloughesy TF; Ellingson BM
Mol Imaging Biol; 2015 Jun; 17(3):434-42. PubMed ID: 25465392
[TBL] [Abstract][Full Text] [Related]
4. Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.
Kurokawa R; Kurokawa M; Baba A; Ota Y; Kim J; Capizzano A; Srinivasan A; Moritani T
Eur Radiol; 2022 Jun; 32(6):3672-3682. PubMed ID: 35022811
[TBL] [Abstract][Full Text] [Related]
5. Voxelwise and Patientwise Correlation of
Tatekawa H; Hagiwara A; Yao J; Oughourlian TC; Ueda I; Uetani H; Raymond C; Lai A; Cloughesy TF; Nghiemphu PL; Liau LM; Pope WB; Salamon N; Ellingson BM
J Nucl Med; 2021 Mar; 62(3):319-325. PubMed ID: 32646876
[TBL] [Abstract][Full Text] [Related]
6. Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas.
Cho NS; Hagiwara A; Eldred BSC; Raymond C; Wang C; Sanvito F; Lai A; Nghiemphu P; Salamon N; Steelman L; Hassan I; Cloughesy TF; Ellingson BM
Neurooncol Adv; 2022; 4(1):vdac124. PubMed ID: 36033919
[TBL] [Abstract][Full Text] [Related]
7. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
8. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
9. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET.
Zhang Y; Lin Y; Xing Z; Yao S; Cao D; Miao WB
Acta Radiol; 2022 May; 63(5):664-671. PubMed ID: 33858207
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.
Calmon R; Dangouloff-Ros V; Varlet P; Deroulers C; Philippe C; Debily MA; Castel D; Beccaria K; Blauwblomme T; Grevent D; Levy R; Roux CJ; Purcell Y; Saitovitch A; Zilbovicius M; Dufour C; Puget S; Grill J; Boddaert N
Eur Radiol; 2021 Dec; 31(12):8913-8924. PubMed ID: 34003354
[TBL] [Abstract][Full Text] [Related]
13. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
14. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
15. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.
Park YW; Ahn SS; Kim EH; Kang SG; Chang JH; Kim SH; Zhou J; Lee SK
Neuroradiology; 2021 Mar; 63(3):363-372. PubMed ID: 32879995
[TBL] [Abstract][Full Text] [Related]
17. Pilot study on evaluation of any correlation between MR perfusion (Ktrans) and diffusion (apparent diffusion coefficient) parameters in brain tumors at 3 Tesla.
Chu JP; Mak HK; Yau KK; Zhang L; Tsang J; Chan Q; Ka-Kit Leung G
Cancer Imaging; 2012 Jan; 12(1):1-6. PubMed ID: 22275724
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
Şahin S; Ertekin E; Şahin T; Özsunar Y
MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
[TBL] [Abstract][Full Text] [Related]
19. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
[TBL] [Abstract][Full Text] [Related]
20. Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.
Thust SC; Maynard JA; Benenati M; Wastling SJ; Mancini L; Jaunmuktane Z; Brandner S; Jäger HR
AJNR Am J Neuroradiol; 2021 Mar; 42(3):441-447. PubMed ID: 33414227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
